MBP
Click for more information
3.23% 3.0¢ metabolic pharmaceuticals limited

pennant breakout, page-15

  1. abeaty
    1,130 Posts.
    lightbulb Created with Sketch. 86
    clock Created with Sketch.
    17/01/07
    14:50
    Post #: 2118781
    "On 18 December 2006 the Company announced the completion of its Phase 2B OPTIONS Study
    for obesity drug AOD9604, the results of which are expected to be announced in March 2007."
    MBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
TPG ACCC says no issue with TPG Telecom and Optus Mobile sharing regional networks; spectrum
right-arrow Created with Sketch.
NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
PV1 Provaris updates on progress with Uniper under hydrogen MOU – not long after interesting ASX response
right-arrow Created with Sketch.
SXG Southern Cross finds large gold-antimony zone underneath historic Victorian mine
right-arrow Created with Sketch.
EBR EBR Systems’ heart pacing device on-target to reach the US market
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.